Verrica Pharmaceuticals Inc
NASDAQ:VRCA 11:10:41 AM EDT
| Market Cap (Intraday) | 125.75M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $3.11 |
| 50-Day MA | $3.52 |
| 200-Day MA | $5.74 |
Verrica Pharmaceuticals Inc Stock, NASDAQ:VRCA
44 West Gay Street, Suite 400, West Chester, Pennsylvania 19380
UNITED STATES OF AMERICA
Phone: +1.434.453.3300
Number of Employees: 38
Description
Verrica Pharmaceuticals, Inc. engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its lead product candidate VP-102, is a proprietary topical therapy used in common skin indications including molluscum contagiosum and verruca vulgaris. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.